Structure |
Chemical Name |
CAS |
MF |
 |
Alogliptin Impurity 22 |
|
|
 |
Afatinib Impurity YHQ |
|
|
 |
Ethyl 4-bromo-3-hydroxybutyrate |
32224-01-4 |
C6H11BrO3 |
 |
Afatinib impurity 84 |
|
|
 |
Benzeneacetic acid, 3-(2-amino-1,1-dimethyl-2-oxoethyl)-α,α-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- |
2469244-33-3 |
C17H22N4O3 |
![1,4-BIS[3,4-DIHYDRO-2(1H)-QUINOLINON-7-OXY]BUTANE](/CAS/GIF/882880-12-8.gif) |
1,4-BIS[3,4-DIHYDRO-2(1H)-QUINOLINON-7-OXY]BUTANE |
882880-12-8 |
C22H24N2O4 |
 |
Aripiprazole N,N-Dioxide |
573691-13-1 |
C23H27Cl2N3O4 |
 |
7-Chloro-4-(4-hydroxyanilino)quinoline |
81099-86-7 |
C15H11ClN2O |
 |
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetaMide) |
120512-03-0 |
C17H21N5O |
 |
Afatinib IMpurity J |
1456696-14-2 |
C18H22N4O4 |
 |
Aripiprazole EP impurity D |
|
|
 |
ETHYL 3,4-EPOXYBUTANOATE |
32223-97-5 |
C6H10O3 |
 |
Alogliptin Impurity A |
|
|
 |
Alcaftadine N-Oxide |
952649-75-1 |
C19H21N3O2 |
 |
Acarbose Impurity B |
|
|
 |
Acarbose Impurity E |
|
|
 |
3-Hydroxy Agomelatine |
166526-99-4 |
C15H17NO3 |
 |
Acarbose Impurity G |
|
|
![Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate]](/CAS/20180629/GIF/CB02995780.gif) |
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
 |
2,3-Dehydrosilybin B |
142796-24-5 |
C25H20O10 |
![monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate)](/CAS/20200119/GIF/CB05441222.gif) |
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
 |
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)-](/CAS/20210305/GIF/104146-11-4.gif) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
 |
diltiazem hydrochloride |
103532-27-0 |
C22H27ClN2O4S |
![2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol](/CAS/GIF/160514-13-6.gif) |
2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol |
160514-13-6 |
C14H12N4O |
![(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid](/CAS/20180702/GIF/1639970-62-9.gif) |
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
 |
Ofloxacin/Levofloxacin Impurity A |
|
|
 |
Afatinib Impurity 53 |
|
|
 |
Afatinib Impurity 68 |
|
|
 |
Agomelatine Impurity 1 |
|
|
 |
Afatinib Impurity 70 |
125781-04-6 |
C4H7ClO2 |
 |
AMIKACIN IMPURITY A |
|
|
 |
Azlocillin Opern-Ring Decarboxylation Impurity |
99795-14-9 |
C19H25N5O5S |
![AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO](/CAS/20211123/GIF/1642629-94-4.gif) |
AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO |
1642629-94-4 |
C16H21N3O6S |
 |
Anastrozole Impurity 13 |
|
|
 |
benidipine |
119009-45-9 |
C28H31N3O6 |
 |
α,α-Dibromo-o-tolunitrile |
655-63-0 |
C8H5Br2N |
 |
D-hydroxyphenylglycylamoxicillin) |
188112-75-6 |
C24H26N4O7S |
 |
1-Hydroxy-7-Methoxy-1,2,3,4-tetrahydronaphthalene |
32820-10-3 |
C11H14O2 |
 |
1-NaphthaleneacetaMide, 1,2,3,4-tetrahydro-7-Methoxy- |
92041-01-5 |
C13H17NO2 |
 |
Deschloroaripiprazole |
203395-81-7 |
C23H28ClN3O2 |
 |
Afatinib IMpurity A |
|
|
 |
Afatinib IMpurity G |
|
|
 |
AlMotriptan Related CoMpound B |
1246860-65-0 |
C19H25N3O6S |
 |
Alogliptin Imp.13 |
|
|
 |
Alogliptin Related Compound 14 |
1820685-30-0 |
C18H23N5O3 |
 |
Alogliptin benzoate impurity K |
1618644-32-8 |
C25H25N5O3 |
 |
Amoxicillin Impurity P |
|
C16H19N3O5S |
 |
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin |
928780-95-4 |
C24H30N8O4 |
 |
Afatinib Impurity 50 |
|
|
 |
Afatinib Impurity 75 |
2348580-72-1 |
C7H14N2O |
 |
Acarbose Impurity IV (JP) |
|
C13H21NO7 |
 |
Azlocillin Impurity 8 |
|
|
 |
3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone |
120004-79-7 |
C13H16ClNO2 |
 |
1-Azetidinesulfonamide(9CI) |
654073-32-2 |
C3H8N2O2S |
 |
N-DESMETHYLGALANTHAMINE |
41303-74-6 |
C16H19NO3 |
 |
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
 |
Adefovir iMpurity |
1875153-79-9 |
C15H24N5O6P |
 |
tert-butyl 4-cyclohexylpiperazine-1-carboxylate |
1224935-95-8 |
C15H28N2O2 |
 |
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
7-PACE Impurity 2 |
|
|
 |
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
 |
EMpagliflozin iMpurity 11 |
|
|
 |
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
![(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid](/CAS/20180702/GIF/CB22995779.gif) |
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate](/CAS/20180702/GIF/CB22995784.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
 |
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
 |
(Glu3)-Carbetocin (Impurity D) |
|
|
 |
Δ3-7-ACT |
|
|
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride](/CAS/20150408/GIF/1038924-71-8.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1)](/) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
![ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20200119/GIF/CB33130105.gif) |
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
 |
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
 |
Lacosamide Impurity – K |
|
|
![(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene](/CAS/20210111/GIF/2229745-37-1.gif) |
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
 |
Ofloxacin/Levofloxacin Impurity B |
|
|
![(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate](/CAS/20200331/GIF/CB45441220.gif) |
(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate |
|
C25H29NO4 |
 |
Amylmetacresol EP impurity A |
876473-73-3 |
C12H18O |
 |
5-methyl-2-(2-methylbutyl)phenol |
|
C12H18O |
 |
7-ADCA Impuirty 1 |
|
|
 |
7-PACE Impurity 1 |
|
|
 |
(R)-Fluvastatin EP Impurity E |
|
|
![5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1391194-45-8.gif) |
5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate |
1391194-45-8 |
C20H21NO3S |
 |
(Gly8-OH)-Carbetocin (Impurity B) |
|
|
 |
D-Asn4-Carbetocin (Impurity F) |
|
|
 |
5-Chloro AcesulfaMe |
72827-08-8 |
C4H4ClNO4S |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate](/CAS/20180703/GIF/1038924-97-8.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
 |
3'-chloro-3'-deoxythymidine (zidovudine impurity) |
|
|
 |
Ofloxacin/Levofloxacin Impurity E |
|
|
 |
4-(4-Hydroxy-3-hydroxymethyl-phenoxy)-benzonitrile |
|
C14H11NO3 |
![monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate)](/CAS/20200401/GIF/CB75441221.gif) |
monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C23H26CaNO5 |
![(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20210111/GIF/2216755-67-6.gif) |
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate |
2216755-67-6 |
C28H37NO5 |
 |
EP Impurity Catalog |
|
|
 |
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
 |
(Asp4)-Carbetocin (Impurity G) |
|
|
 |
((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
115540-28-8 |
C40H72O2Si2 |
 |
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
2-Hydroxymethyl Olanzapine |
174756-45-7 |
C17H20N4OS |
 |
Flomoxef Impurity 2 |
|
|
 |
4-Isobutylacetophenone (Ibuprofen impurity) |
|
|